International Xenotransplantation Association Update

IHCTAS 2013

It is with great pleasure that we would like to announce the 12th Congress of the International Xenotransplantation Association (IXA), which will be held jointly with the iABO/Hyper Immune Symposium in Osaka, Japan, from November 10–13, 2013.

Osaka is the capital city of the western province of Japan, located an hour’s drive from the traditional old cities of Kyoto & Nara. The program of our joint meeting has been designed with 17 experts from 9 countries and developed to promote a truly interdisciplinary exchange of scientific progress and concepts among investigators active in two different, but increasingly related and overlapping fields. The program will thus provide an excellent forum for both clinical investigators and basic scientists with expertise in ABO-incompatible transplantation and xenotransplantation to meet and discuss innovative strategies for overcoming antibody-mediated rejection, organ shortage, and other obstacles, such as coagulation dysregulation. IXA will open the Call for Abstracts on March 15, 2013 - and registration will be available online through the website starting on April 12, 2013. For updates on the congress please visit www.ixa2013.org.

We would also like to announce the inaugural awarding of the Carl-Gustav Groth Xeno Prize. Jointly funded by the International Xenotransplantation Association (IXA) and the publisher of Xenotransplantation (Wiley), this new prize of $7,000 USD­­­ acknowledges the seminal contributions made by Dr. Groth to the field of xenotransplantation and honours the first author of the best paper published in the journal in each calendar year. We would like to therefore congratulate Dr. Christopher Burlak, Assistant Professor of Surgery at Indiana University, as the first winner of the Carl-Gustav Groth Xeno Prize. His manuscript entitled: “Identification of human preformed antibody targets in GTKO pigs” was judged by the Xeno Prize Committee to be the best of all papers published in Xenotransplantation in 2012.

Please do not hesitate to contact IXA at This email address is being protected from spambots. You need JavaScript enabled to view it. to communicate your suggestions.

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi